You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Pharmaceuticals

since 2025 › Apr › 22 (Tue) @ 23:40 UTC

auto-detected in 5 stories

5 months ago

Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial ○

found 2025 › Sep › 25 (Thu) @ 06:25 UTC

a story from CNBC ⚠️ › Top News

Roche Pharmaceuticals' CEO told investors she was "serious" about the goal of becoming a top 3 obesity player.

9 months ago

23andMe to delist from Nasdaq, deregister with SEC ○

found 2025 › May › 27 (Tue) @ 19:30 UTC

a story from CNBC ⚠️ › Top News

Regeneron Pharmaceuticals said earlier this month that it will acquire "substantially all" of 23andMe's assets for $256 million.

Regeneron Pharmaceuticals to buy 23andMe and its data for $256 million ○

found 2025 › May › 19 (Mon) @ 18:35 UTC

a story from CNBC ⚠️ › Top News

Regeneron is acquiring "substantially all" of 23andMe's assets for $256 million following a bankruptcy auction.

10 months ago

How Takeda's CEO transformed the company into a global pharma powerhouse ○

found 2025 › Apr › 23 (Wed) @ 03:55 UTC

a story from CNBC ⚠️ › Top News

Takeda Pharmaceuticals, Japan's largest drugmaker, has undergone a sweeping transformation under CEO Christophe Weber, emerging as one of the world's leading pharmaceutical companies.

How Takeda's CEO transformed the company into a global pharma powerhouse ○

found 2025 › Apr › 22 (Tue) @ 23:25 UTC

a story from CNBC ⚠️ › World News

Takeda Pharmaceuticals, Japan's largest drugmaker, has undergone a sweeping transformation under CEO Christophe Weber, emerging as one of the world's leading pharmaceutical companies.

page 1 of 1